Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VYxeoS Liposomal Italian Observational Study iN the Real Practice

NCT06143839 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.

NCT NCT06143839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06143839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VYxeoS Liposomal Italian Observational Study iN the Real Practice
Lead sponsor
Jazz Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
December 7, 2023
Completion date
October 23, 2025
Enrollment
113 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), acute myeloid leukemia with myelodysplasia-related changes, therapy-related acute myeloid leukemia